Literature DB >> 30565136

CRISPR-Mediated Approaches to Regulate YAP/TAZ Levels.

Ryan J Quinton1, Neil J Ganem2,3.   

Abstract

The advent of CRISPR has revolutionized genomic engineering, and harnessing its power to regulate levels of the transcriptional co-activators YAP and TAZ represents an exciting new opportunity in the field of Hippo signaling. Initially repurposed from the microbial immune system to perform highly specific gene knockouts, CRISPR technology has now been expanded to modulate the transcriptional activity of any gene of interest in mammalian systems. Here, we describe strategies to employ CRISPR to genetically knock out the genes encoding for YAP (YAP1) or TAZ (WWTR1) in mammalian cell lines, as well as briefly outline an approach for utilizing CRISPR to transcriptionally modulate YAP/TAZ levels.

Entities:  

Keywords:  CRISPRa; CRISPRi; Cas9; Hippo; KRAB; LATS; VP64; sgRNA

Mesh:

Substances:

Year:  2019        PMID: 30565136      PMCID: PMC6533617          DOI: 10.1007/978-1-4939-8910-2_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  44 in total

1.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

2.  The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.

Authors:  Noriyuki Nishioka; Ken-ichi Inoue; Kenjiro Adachi; Hiroshi Kiyonari; Mitsunori Ota; Amy Ralston; Norikazu Yabuta; Shino Hirahara; Robert O Stephenson; Narumi Ogonuki; Ryosuke Makita; Hiroki Kurihara; Elizabeth M Morin-Kensicki; Hiroshi Nojima; Janet Rossant; Kazuki Nakao; Hitoshi Niwa; Hiroshi Sasaki
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

Review 3.  CRISPR/Cas, the immune system of bacteria and archaea.

Authors:  Philippe Horvath; Rodolphe Barrangou
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

4.  Hippo pathway regulation by cell morphology and stress fibers.

Authors:  Ken-Ichi Wada; Kazuyoshi Itoga; Teruo Okano; Shigenobu Yonemura; Hiroshi Sasaki
Journal:  Development       Date:  2011-08-10       Impact factor: 6.868

5.  The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

Authors:  Jianbin Huang; Shian Wu; Jose Barrera; Krista Matthews; Duojia Pan
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

Review 6.  Evolution and classification of the CRISPR-Cas systems.

Authors:  Kira S Makarova; Daniel H Haft; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Yuri I Wolf; Alexander F Yakunin; John van der Oost; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2011-05-09       Impact factor: 60.633

7.  Expression of Yes-associated protein in common solid tumors.

Authors:  Angela A Steinhardt; Mariana F Gayyed; Alison P Klein; Jixin Dong; Anirban Maitra; Duojia Pan; Elizabeth A Montgomery; Robert A Anders
Journal:  Hum Pathol       Date:  2008-08-13       Impact factor: 3.466

8.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

9.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

Authors:  F J M Mojica; C Díez-Villaseñor; J García-Martínez; C Almendros
Journal:  Microbiology       Date:  2009-03       Impact factor: 2.777

10.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.